MBrace Therapeutics’ Post

View organization page for MBrace Therapeutics, graphic

1,695 followers

It is an honor to be recognized by BioPharma Reporter as one of the top #ADC startups favored by venture capital #investors in 2023. Read the full article to discover how we’re making strides in the #oncology space following our our $85 million Series B financing led by TPGhttps://lnkd.in/efTvW7xV #cancer #biotech #innovation #science #stem 

The top 5 ADC startups favoured by venture capital investors

The top 5 ADC startups favoured by venture capital investors

biopharma-reporter.com

To view or add a comment, sign in

Explore topics